List of Excipients in API rifabutin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing rifabutin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | MYCOBUTIN | rifabutin | 0013-5301 | CELLULOSE, MICROCRYSTALLINE | |
| Pfizer Laboratories Div Pfizer Inc | MYCOBUTIN | rifabutin | 0013-5301 | FERRIC OXIDE RED | |
| Pfizer Laboratories Div Pfizer Inc | MYCOBUTIN | rifabutin | 0013-5301 | MAGNESIUM STEARATE | |
| Pfizer Laboratories Div Pfizer Inc | MYCOBUTIN | rifabutin | 0013-5301 | SILICON DIOXIDE | |
| Pfizer Laboratories Div Pfizer Inc | MYCOBUTIN | rifabutin | 0013-5301 | SODIUM LAURYL SULFATE | |
| Pfizer Laboratories Div Pfizer Inc | MYCOBUTIN | rifabutin | 0013-5301 | TITANIUM DIOXIDE | |
| Physicians Total Care Inc | MYCOBUTIN | rifabutin | 54868-2841 | CELLULOSE, MICROCRYSTALLINE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing rifabutin
Detailed excipient profiles for rifabutin
Excipient focus: ALCOHOL
rifabutin drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | rifabutin | 10135-738 |
| Novitium Pharma LLC | rifabutin | 70954-041 |
| >Company | >Ingredient | >NDC |
rifabutin drug variants not containing ALCOHOL
Excipient focus: AMMONIA
rifabutin drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | rifabutin | 10135-738 |
| Novitium Pharma LLC | rifabutin | 70954-041 |
| >Company | >Ingredient | >NDC |
rifabutin drug variants not containing AMMONIA
Excipient focus: BUTYL ALCOHOL
rifabutin drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | rifabutin | 10135-738 |
| Novitium Pharma LLC | rifabutin | 70954-041 |
| >Company | >Ingredient | >NDC |
rifabutin drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
rifabutin drug variants containing CELLULOSE, MICROCRYSTALLINE
rifabutin drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | rifabutin | 68180-285 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
rifabutin drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | rifabutin | 68180-285 |
| >Company | >Ingredient | >NDC |
rifabutin drug variants not containing CROSPOVIDONE
Excipient focus: FERRIC OXIDE RED
rifabutin drug variants containing FERRIC OXIDE RED
rifabutin drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
rifabutin drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | rifabutin | 10135-738 |
| Novitium Pharma LLC | rifabutin | 70954-041 |
| >Company | >Ingredient | >NDC |
rifabutin drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
rifabutin drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | rifabutin | 10135-738 |
| Lupin Pharmaceuticals Inc | rifabutin | 68180-285 |
| Novitium Pharma LLC | rifabutin | 70954-041 |
| >Company | >Ingredient | >NDC |
rifabutin drug variants not containing GELATIN
Excipient focus: ISOPROPYL ALCOHOL
rifabutin drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | rifabutin | 10135-738 |
| Novitium Pharma LLC | rifabutin | 70954-041 |
| >Company | >Ingredient | >NDC |
rifabutin drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: MAGNESIUM STEARATE
rifabutin drug variants containing MAGNESIUM STEARATE
rifabutin drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
rifabutin drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | rifabutin | 68180-285 |
| >Company | >Ingredient | >NDC |
rifabutin drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: POTASSIUM HYDROXIDE
rifabutin drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | rifabutin | 10135-738 |
| Lupin Pharmaceuticals Inc | rifabutin | 68180-285 |
| Novitium Pharma LLC | rifabutin | 70954-041 |
| >Company | >Ingredient | >NDC |
rifabutin drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: PROPYLENE GLYCOL
rifabutin drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | rifabutin | 10135-738 |
| Novitium Pharma LLC | rifabutin | 70954-041 |
| >Company | >Ingredient | >NDC |
rifabutin drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
rifabutin drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | rifabutin | 10135-738 |
| Lupin Pharmaceuticals Inc | rifabutin | 68180-285 |
| Novitium Pharma LLC | rifabutin | 70954-041 |
| >Company | >Ingredient | >NDC |
rifabutin drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
rifabutin drug variants containing SILICON DIOXIDE
rifabutin drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
rifabutin drug variants containing SODIUM LAURYL SULFATE
rifabutin drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
rifabutin drug variants containing TITANIUM DIOXIDE
rifabutin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
rifabutin drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | rifabutin | 10135-738 |
| Novitium Pharma LLC | rifabutin | 70954-041 |
| >Company | >Ingredient | >NDC |
rifabutin drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch